About Pfizer
Pfizer Inc. is one of the world's premier biopharmaceutical companies, discovering, developing, and delivering innovative vaccines and medicines across the globe. With a history spanning over 175 years, Pfizer has been at the forefront of medical breakthroughs that change patients' lives.
Our Legacy
Founded in 1849 in Brooklyn, New York, by Charles Pfizer and Charles Erhart, Pfizer has grown from a fine-chemicals business into a global biopharmaceutical leader. The company made history in 2020 by developing one of the first COVID-19 vaccines in partnership with BioNTech.
Research & Development
Pfizer invests billions annually in R&D across therapeutic areas including oncology, immunology, rare diseases, and vaccines. The company's pipeline includes cutting-edge mRNA technology, gene therapies, and targeted cancer treatments.
Therapeutic Areas
Pfizer is a leader in oncology with drugs like Ibrance and Xtandi, vaccines including Prevnar and the COVID-19 vaccine, and specialty medicines for inflammatory conditions and rare diseases. The company serves patients in over 125 countries.
Global Reach
Headquartered in New York City, Pfizer operates manufacturing facilities and research labs worldwide, employing over 83,000 people across 175 countries. The company generated $58.5 billion in revenue in 2023.
Leadership
Dr. Albert Bourla serves as Chairman and CEO, having led Pfizer through one of the most significant periods in its history. Under his leadership, Pfizer delivered the COVID-19 vaccine in record time and continues to advance its pipeline.